3 clinically-studied ingredients
How do GLP-1 RAs work
In October 2017, following a unanimous FDA Advisory Committee approval, the injectable version (Ozempic) was approved for diabetes treatment in the US and later in other countries, including: Canada European Union Japan Australia The oral version (Rybelsus) received US approval in September 2019, with EU approval in April 2020
While direct, head-to-head quantitative half-life data in identical assay systems is lacking for this specific molecule, the principle is a well-established class-level inference in lipid biology and is supported by its recommended storage conditions (stable at -20C, compared to more stringent storage requirements for labile esters)
Most patients experience shedding 2 to 3 months after starting treatment, with regrowth beginning once weight stabilizes
Handling Side Effects: Common side effects include nausea, vomiting, and diarrhea, especially when starting or increasing the dose
